VIGLIETTO, GIUSEPPE
VIGLIETTO, GIUSEPPE
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility.
2011 Pierantoni GM; Esposito F; Tornincasa M; Rinaldo C; Viglietto G; Soddu S; Fusco A.
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
2006 Iervolino, A; Iuliano, R; Trapasso, F; Viglietto, G; Melillo, Rm; Carlomagno, F; Santoro, M; Fusco, A
A new mechanism of BRAF activation in human thyroid papillary carcinomas.
2005 Fusco, A; Viglietto, G; Santoro, M
Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
2005 Motti, Ml; Califano, D; Troncone, G; De Marco, C; Migliaccio, I; Palmieri, E; Pezzullo, L; Palombini, L; Fusco, A; Viglietto, G
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
2005 Di Vizio, D; Cito, L; Boccia, A; Chieffi, P; Insabato, L; Pettinato, G; Motti, Ml; Schepis, F; D'Amico, W; Fabiani, F; Tavernise, B; Venuta, S; Fusco, A; Viglietto, G
Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas.
2005 Fusco, A; Viglietto, G; Santoro, M
The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
2005 Pera, Il; Iuliano, R; Florio, T; Susini, C; Trapasso, F; Santoro, M; Chiariotti, L; Schettini, G; Viglietto, G; Fusco, A
The transcriptional repressor DREAM is involved in thyroid gene expression.
2005 D'Andrea B; Di Palma T; Mascia A; Motti ML; Viglietto G; Nitsch L; Zannini M.
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
2005 Fedele M; Pentimalli F; Baldassarre G; Battista S; KleinSzanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A.
UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.
2005 P Pallante; MT Berlingieri; G Troncone; M Kruhoffer; TF Orntoft; G Viglietto; A Caleo; I Migliaccio;M DecaussinPetrucci; M Santoro; L Palombini;A Fusco;
Akt-dependent T198 phosphorylation of cicli-dependent kinase inhibitor p27kip1 in breast cancer.
2004 Motti, Ml; De Marco, C; Califano, D; Fusco, A; Viglietto, G
High mobility group A1 expression correlates with the histological grade of human glial tumors.
2004 Donato, G; Martinez Hoyos, J; Amorosi, A; Maltese, L; Lavano, A; Volpentesta, G; Signorelli, F; Pentimalli, F; Pallante, P; Ferraro, G; Tucci, L; Signorelli, Cd; Viglietto, G; Fusco, A
Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells.
2004 Vitagliano D; Carlomagno F; Motti ML; Viglietto G; Nikiforov YE; Nikiforova MN;Hershman JM; Ryan AJ; Fusco A; Melillo RM; Santoro M.
Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models.
2004 Trapasso, F; Sarti, M; Cesari, R; Yendamuri, S; Dumon, Kr; Aqeilan, Ri; Pentimalli, F; Infante, L; Alder, H; Abe, N; Watanabe, T; Viglietto, G; Croce, Cm; Fusco, A
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas.
2003 Pierantoni, Gm; Battista, S; Pentimalli, F; Fedele, M; Visone, R; Federico, A; Santoro, M; Viglietto, G; Fusco, A
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
2003 Iuliano, R; Trapasso, F; Le Pera, I; Schepis, F; Sama, I; Clodomiro, A; Dumon, Kr; Santoro, M; Chiariotti, L; Viglietto, G; Fusco, A
Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland.
2003 Motti, Ml; Boccia, A; Belletti, B; Bruni, P; Troncone, G; Cito, L; Monaco, M; Chiappetta, G; Baldassarre, G; Palombini, L; Fusco, A; Viglietto, G
DREAM is a transcriptional repressor involved in thyroid differentiation and function
2003 Dandrea, B; Di Palma, T; Macchia, Pe; Terracciano, D; Motti, Ml; Viglietto, G; Mascia, A; Macchia, V; Di Lauro, R; Zannini, M
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
2003 Masciullo V. ; Baldassarre G. ; Pentimalli F. ; Berlingieri M.T. ; Boccia A. ; Chiappetta G. ; Palazzo J. ; Manfioletti G. ; Giancotti V. ; Viglietto G. ; Scambia G. ; Fusco A.
Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples.
2002 Curci, A; Capasso, I; Romano, A; Bruni, P; Motti, Ml; Pignata, S; D'Aiuto, G; Casamassimi, A; D'Urso, M; Fusco, A; Viglietto, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility. | 1-gen-2011 | Pierantoni GM; Esposito F; Tornincasa M; Rinaldo C; Viglietto G; Soddu S; Fusco A. | |
| The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins. | 1-gen-2006 | Iervolino, A; Iuliano, R; Trapasso, F; Viglietto, G; Melillo, Rm; Carlomagno, F; Santoro, M; Fusco, A | |
| A new mechanism of BRAF activation in human thyroid papillary carcinomas. | 1-gen-2005 | Fusco, A; Viglietto, G; Santoro, M | |
| Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. | 1-gen-2005 | Motti, Ml; Califano, D; Troncone, G; De Marco, C; Migliaccio, I; Palmieri, E; Pezzullo, L; Palombini, L; Fusco, A; Viglietto, G | |
| Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. | 1-gen-2005 | Di Vizio, D; Cito, L; Boccia, A; Chieffi, P; Insabato, L; Pettinato, G; Motti, Ml; Schepis, F; D'Amico, W; Fabiani, F; Tavernise, B; Venuta, S; Fusco, A; Viglietto, G | |
| Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. | 1-gen-2005 | Fusco, A; Viglietto, G; Santoro, M | |
| The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. | 1-gen-2005 | Pera, Il; Iuliano, R; Florio, T; Susini, C; Trapasso, F; Santoro, M; Chiariotti, L; Schettini, G; Viglietto, G; Fusco, A | |
| The transcriptional repressor DREAM is involved in thyroid gene expression. | 1-gen-2005 | D'Andrea B; Di Palma T; Mascia A; Motti ML; Viglietto G; Nitsch L; Zannini M. | |
| Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. | 1-gen-2005 | Fedele M; Pentimalli F; Baldassarre G; Battista S; KleinSzanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A. | |
| UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. | 1-gen-2005 | P Pallante; MT Berlingieri; G Troncone; M Kruhoffer; TF Orntoft; G Viglietto; A Caleo; I Migliaccio;M DecaussinPetrucci; M Santoro; L Palombini;A Fusco; | |
| Akt-dependent T198 phosphorylation of cicli-dependent kinase inhibitor p27kip1 in breast cancer. | 1-gen-2004 | Motti, Ml; De Marco, C; Califano, D; Fusco, A; Viglietto, G | |
| High mobility group A1 expression correlates with the histological grade of human glial tumors. | 1-gen-2004 | Donato, G; Martinez Hoyos, J; Amorosi, A; Maltese, L; Lavano, A; Volpentesta, G; Signorelli, F; Pentimalli, F; Pallante, P; Ferraro, G; Tucci, L; Signorelli, Cd; Viglietto, G; Fusco, A | |
| Regulation of p27Kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells. | 1-gen-2004 | Vitagliano D; Carlomagno F; Motti ML; Viglietto G; Nikiforov YE; Nikiforova MN;Hershman JM; Ryan AJ; Fusco A; Melillo RM; Santoro M. | |
| Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. | 1-gen-2004 | Trapasso, F; Sarti, M; Cesari, R; Yendamuri, S; Dumon, Kr; Aqeilan, Ri; Pentimalli, F; Infante, L; Alder, H; Abe, N; Watanabe, T; Viglietto, G; Croce, Cm; Fusco, A | |
| A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas. | 1-gen-2003 | Pierantoni, Gm; Battista, S; Pentimalli, F; Fedele, M; Visone, R; Federico, A; Santoro, M; Viglietto, G; Fusco, A | |
| An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. | 1-gen-2003 | Iuliano, R; Trapasso, F; Le Pera, I; Schepis, F; Sama, I; Clodomiro, A; Dumon, Kr; Santoro, M; Chiariotti, L; Viglietto, G; Fusco, A | |
| Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland. | 1-gen-2003 | Motti, Ml; Boccia, A; Belletti, B; Bruni, P; Troncone, G; Cito, L; Monaco, M; Chiappetta, G; Baldassarre, G; Palombini, L; Fusco, A; Viglietto, G | |
| DREAM is a transcriptional repressor involved in thyroid differentiation and function | 1-gen-2003 | Dandrea, B; Di Palma, T; Macchia, Pe; Terracciano, D; Motti, Ml; Viglietto, G; Mascia, A; Macchia, V; Di Lauro, R; Zannini, M | |
| HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas. | 1-gen-2003 | Masciullo V. ; Baldassarre G. ; Pentimalli F. ; Berlingieri M.T. ; Boccia A. ; Chiappetta G. ; Palazzo J. ; Manfioletti G. ; Giancotti V. ; Viglietto G. ; Scambia G. ; Fusco A. | |
| Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples. | 1-gen-2002 | Curci, A; Capasso, I; Romano, A; Bruni, P; Motti, Ml; Pignata, S; D'Aiuto, G; Casamassimi, A; D'Urso, M; Fusco, A; Viglietto, G |